Home > Events > Veristat oct east coast 2026

1 min read

Connect with Veristat at OCT East Coast

May 11-15, 2026 – Boston, MA

⚛️ Where Clinical Operations Meet Real-World Execution

Veristat is pleased to attend OCT East Coast 2026, a leading event for clinical operations leaders focused on the realities of trial execution. As protocols grow more complex and timelines compress, success depends on more than activity. It depends on alignment, discipline, and decisions that hold up under pressure.

Our team looks forward to connecting with clinical and operational leaders to discuss how Veristat helps sponsors reduce rework, improve decision speed, and make every dollar of development capital count.

👥 Meet with us at OCT East Coast

Connect with us to explore how Veristat’s scientific leadership and focused capabilities support confident decisions and efficient progress across clinical and regulatory milestones.

📅 Schedule a meeting in advance

 Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy. 

💡 Our Expertise

Veristat’s work centers on the capabilities sponsors need most as programs move toward key development and regulatory milestones:

  • Phase I-II Clinical Development 

  • Biostatistics and Data-Driven Evidence

  • Global Regulatory Strategy & Submissions

Together, these capabilities help sponsors move from study design to submission with clarity, reduce rework, and accelerate progress toward patients while preserving development capital.

Share This Event:

   

3 min read

Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works

When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...

3 min read

The Psychedelic Setback: What MDMA Rejection Taught Drug Developers

In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...